ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,927, issued on June 3, was assigned to Healing Genes LLC (New York) and Panacea Venture Healthcare Fund I LP (Shanghai).
"Genetic construct" was invented by Michael McDonald (Guildford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "A genetic construct comprises a promoter operably linked to a first coding sequence, which encodes tyrosine hydroxylase (TH), and a second coding sequence, which encodes GTP cyclohydrolase 1 (GCH1), wherein the second coding sequence is 3' to the first coding sequence, and the first and second coding sequences are part of a single operon. The genetic construct does not encode aromatic amino acid decarboxylas...